Oak Ridge Lab Produces Rhenium-188 Isotope

Researcher Haswitha Sabbineni is advancing a targeted treatment strategy for prostate cancer that requires a specific radioactive isotope to move from theoretical design to experimental validation. To secure the necessary material, Sabbineni turned to the Department of Energy’s Oak Ridge National Laboratory, tapping into the facility’s specialized production capabilities to support emerging oncology research. The collaboration reflects a broader trend in medical science, where precision radiopharmaceuticals are being developed to deliver therapeutic doses directly to tumor sites while sparing surrounding healthy tissue.

Oak Ridge National Laboratory is one of a limited number of facilities globally equipped to synthesize and process rare isotopes for medical and scientific use.